Estimating the impact of overweight and obesity on cancer risk in the Czech and Slovak populations

Česká verze

Authors: K. Rožeková; M. Lustigová
Authors place of work: Katedra sociální geografie a regionálního rozvoje PřF UK, Praha
Published in the journal: Epidemiol. Mikrobiol. Imunol. 68, 2019, č. 4, s. 168-175
Category: Původní práce

Summary

Aim: To estimate and compare the 2016 numbers and proportions of deaths from selected types of malignant neoplasms attributable to high body mass index (BMI) from 2008 in the Czech and Slovak populations.

Material and methods: The estimated impact of overweight and obesity on the risk of malignant neoplasms in the Czech and Slovak populations was calculated using the population attributable fraction (PAF).

Results: It is estimated that 2 120 deaths in the Czech Republic and 1 073 deaths in the Slovak Republic in 2016 could be attributable to high BMI. The highest PAF was observed for oesophagal adenocarcinoma in all age categories regardless of sex and country.

Conclusions: It can be stated that high BMI has an impact on selected types of malignant neoplasms. A generally higher PAF was observed for females. At the same time, females showed an increasing PAF with increasing age. This can be explained by weight increase with age in the ageing female population.

Keywords:

prevention – overweight and obesity – malignant neoplasm – Czech population – Slovak population

Zdroje

1. Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. The Lancet Oncology, 2015;16(1):36–46.

2. Arnold M, Touillaudb M, Dossus L, et al. Cancers in France in 2015 attributable to high body mass index. Cancer Epidemiology, 2018;52:15–19.

3. Basen-Engquist K, Chang M. Obesity and Cancer Risk: Recent Review and Evidence. Current Oncology Reports, 2011;13(1):71–76.

4. Barrett J. Early Obesity Increases Risk of 8 Types of Cancer Later in Life. Specialty Pharmacy Times, 2018;9(6).

5. Berger NA. Obesity and cancer pathogenesis. Annals of the New York Academy of Sciences, 2014;1311:57–76.

6. Berger NA. Young Adult Cancer: Influence of the Obesity Pandemic. Obesity, 2018;26(4): 641–650.

7. Bergström A, Pisani P, Tenet V, et al. Overweight as an avoid-able cause of cancer in Europe. International Journal of Cancer, 2001;91(3):421–430.

8. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. The Lancet Oncologys, 2002;3(9):565–574.

9. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. The New England Journal of Medicine, 2003;348(17):1625–1638.

10. Calle EE, Thun MJ. Obesity and cancer. Oncogene, 2004;23:6365–6378.

11. Cleary MP. Impact of obesity on development and progression of mammary tumors in preclinical models of breast cancer. Journal of Mammary Gland Biol Neoplasia, 2013;18:333–343.

12. Český statistický úřad [online]. Demografická ročenka České republiky – 2016 [cit 2018-12-07]. Dostupné na www: https://www.czso.cz/csu/czso/demograficka-rocenka-ceske-republiky-2016.

13. Dawson DW, Hertzer K, Moro A, et al. High-fat, high-calorie diet promotes early pancreatic neoplasia in the conditional KrasG12D mouse model. Cancer Prev Res (Phila), 2013;6(10):1064–1073.

14. Doerner SK, Reis ES, Leung ES, et al. High-fat diet-induced complement activation mediates intestinal inflammation and neoplasia, independent of obesity. Molecular Cancer Research, 2016;14(10):953–965.

15. Dougan MM, Hankinson SE, Vivo ID, et al. Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women. International Journal of Cancer, 2015;137(3):625–37.

16. Field AE, Eugenie H, Must A, et al. Impact of Overweight on the Risk of Developing Common Chronic Diseases During a 10-Year Period. JAMA Internal Medicine, 2001;161(13):1581–1586.

17. Hidayat K, Shi BM. Body fatness at a young age and risks of eight types of cancer: systematic review and meta-analysis of observational studies. Obesityreviews, 2018;19(10):1385–1394.

18. Chow WH, Gridley G, Fraumeni JF, Järvholm B. Obesity, hypertension, and the risk of kidney cancer in men. The New England Journal of Medicine, 2000;343(18):1305–1311.

19. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiology, Biomarkers & Prevention, 2002;11(12):1531–4153.

20. Key TJ, Allen NE, Verkasalo PK, Banks E. Energy balance and cancer: the role of sex hormones. Proceedings of the Nutrition Society, 2001;60(1):81–89.

21. Li L, Gan Y, Li W, et al. Overweight, obesity and the risk of gallbladder and extrahepatic bile duct cancers: A meta-analysis of observational studies. Obesity (Silver Spring), 2016;24(8):1786–1802.

22. Lukanová A, Björ O, Kaaks R, et al. Body mass index and cancer: Results from the Northern Sweden Health and Disease Cohort. International Journal of Cancer, 2005;118(2):458–466.

23. Ma Y, Yang Y, Wang F, et al. Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies. PLoS One, 2013;8(1):e53916.

24. Pan SY, Johnson KC, Ugnat AM, et al. Association of obesity and cancer risk in Canada. American Journal of Epidemiology, 2004;159(3):259–268.

25. Parekh N, Chandran U, Bandera EV. Obesity in Cancer Survival. Annual Review of Nutrition, 2012;32:311–342.

26. Parkin DM, Boyd L. Cancers attributable to overweight and obesity in the UK in 2010. British Journal of Cancer, 2011;105(2):S34–S37.

27. Pearson-Stuttard J, Zhou B, Kontis V, et al. Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. The Lancet Diabetes and Endocrinology, 2018;6(6):6–15.

28. Pischon T, Nimptsch K. Obesity and Risk of Cancer: An Introductory Overview. Recent Results in Cancer Research, 2016;208:1–15.

29. Quante M, Bhagat G, Abrams JA, et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell, 2012;21(1):36–51.

30. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 2008;371(9612):569–578.

31. Se K, Shim KN, Jung SA, Yoo K, Moon IH. An association between obesity and the prevalence of colonic adenoma according to age and gender. The Journal of Gastroenterology, 2007;42(8):616–623.

32. Setiawan VW, Yang HP, Pike MC, et al. Type I and II endometrial cancers: have they different risk factors? Journal of Clinical Oncology, 2013;31(20):2607–2618.

33. Schmid D, Leitzmann MF. Television viewing and time spent sedentary in relation to cancer risk: a meta-analysis. Journal of the National Cancer Institute, 2014;106(7).

34. Štatistický úrad SR [online]. Databáza časových radov SLOVSTAT [cit 2018-12-07]. Dostupné na www: < http://www.statistics.sk/pls/elisw/vbd>

35. Taghizadeh N, Boezen HM, Schouten J, et al. BMI and Lifetime Changes in BMI and Cancer Mortality Risk. PLoS One, 2015;10(4):e0125261.

36. Ústav zdravotnických informací a statistiky ČR [online]. Evropské výběrové šetření o zdraví v České republice EHIS 2008 [cit 2018-12-07]. Dostupné na www: https://www.uzis.cz/publikace/evropske-vyberove-setreni-zdravi-ceske-republice-ehis-2008.

37. Vainio H, Kaaks R, Bianchini F. Weight control and physical activity in cancer prevention: international evaluation of the evidence. European Journal of Cancer Prevention, 2002;11(2):S94–S100.

38. Vágnerová M. Vývojová psychologie II. Praha: Karolinum; 2007.

39. Wang F, Xu Y. Body mass index and risk of renal cell cancer: a dose-response meta-analysis of published cohort studies. International Journal of Cancer, 2014;135(7):1673–1686.

40. World Cancer Research Fund [online]. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective [cit 2018-12-10]. Dostupné na www: <http://www.aicr.org/assets/docs/pdf/reports/Second_Expert_Report.pdf>

41. World Cancer Research Fund [online]. Body fatness and weight gain and the risk of cancer [cit 2018-1-15]. Dostupné na www: < https://www.wcrf.org/sites/default/files/Body-fatness-and-weight--gain.pdf>

42. World Cancer Research Fund International [online]. Obesity [cit 2019-01-07].

Dostupné na www: < https://www.wcrf.org/sites/default/files/Gallbladder-Cancer-2015-Report.pdfExit%20Disclaimer>

43. World Health Organization [online]. Cancer [cit 2019-01-05]. Dostupné na www: <http://www.who.int/news-room/fact-sheets/detail/cancer>

44. World Health Organization [online]. Prevalence of obesity among adults, BMI ≥ 30, crude Estimates by country [cit 2019-01-05]. Dostupné na www: < http://apps.who.int/gho/data/view.main.BMI30Cv?lang=en>

45. WHO. Obesity. [online] [cit 2019-01-05]. Dostupné na www: < https://www.who.int/gho/ncd/risk_factors/obesity_text/en/>

46. WHO. Metrics: Population Attributable Fraction (PAF). [online] [cit 2018-12-10]. Dostupné na www: <https://www.who.int/healthinfo/global_burden_disease/metrics_paf/en/>

47. Reeves GK, Pirie, K, Beral, V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. The British Medical Journal, 2007;335(7630):1134.

48. Santana, Costam, Freitas (ed.) Cataloging Internet resource: Atlas of population health in European Union regions [on line]. Imprensa da Universidade de Coimbra, c2017[cit. 2019-02-25]. Dostupné na www: https://digitalis.uc.pt/en/livro/atlas_population_health_european_union_regions>. ISBN 978-989-26-1463-2.

49. Townsend N, Wilson L, Bhatnagar P, et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart Journal, 2016;37(42):3232–3245.

50. Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. The Lancet Oncologys, 2012;13(8):790–801.

51. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015;65(2):87–108.

52. Anand P, Kunnumakara AB, Sundaram C, et al. Cancer is a Preventable Disease that Requires Major Lifestyle Changes. Pharmaceutical Research, 2008;25(9):2097–2116.

53. Autier, Boffetta, Boniol (ed.) Cataloging Internet resource: Attributable Causes of Cancer in France in the Year 2000 [on line]. Lyon, France: International Agency for Research on Cancer, c2000[cit. 2019-02-25]. Dostupné na www:< https:// https://www.academie-sciences.fr/archivage_site/activite/rapport/rapport130907gb.pdf>. ISBN 978-92-832-2443-4.

54. Bosakova L, Rosicova K, Filakovska Bobakova D, et al. Mortality in the Visegrad countries from the perspective of socioeconomic inequalities. International Journal of Public Health, 2019;64(3):365–376.

55. Karvonen-Gutierrez C, Kim C. Association of Mid-Life Changes in Body Size, Body Composition and Obesity Status with the Menopausal Transition. Healthcare (Basel), 2016;4(3):42.

56. Medical Tribune [online]. Abdominální obezita a kardiovaskulární riziko [cit 2019-9-27].

Dostupné na www: < https://www.tribune.cz/clanek/8022-abdominalni-obezita-a-kardiovaskularni-riziko>

57. Campo-Verde-Arbocco F, López-Laur JD, Romeo LR, et al. Human renal adipose tissue induces the invasion and progression of renal cell carcinoma. Oncotarget, 2007;8(55):94223–94234.

58. Nieman KM, Romero IL, Houten BV, et al. Adipose tissue and adi-pocytes supports tumorigenesis and metastasis. Biochim Biophys Acta, 2013;1831(10):1533–1541.

59. Nakajima TE, Yamada Y, Hamano T, et al. Adipocytokines and squa-mous cell carcinoma of the esophagus. Journal of Cancer Research and Clinical Oncology, 2010;136(2):261–266.

60. Kauppila A. Progestin Therapy of Endometrial, Breast and Ovarian Carcinoma: A review of clinical observations. Acta Obstetricia et Gynecologica Scandinavica, 2009;63(5):441–445.